UCB spent decades shedding its industrial past to become a specialist in the brain and immune system. Now five medicines, two ambitious acquisitions and a new Georgia factory are testing whether focus can scale.
Courier Health is a New York City software company building the first patient relationship management (CRM) platform purpose-built for life sciences. Its AI-powered system connects fragmented data across biopharma commercial teams to orchestrate the patient journey - from education and enrollment through benefits, prior authorization, therapy initiation, and adherence - helping patients with chronic and rare diseases start and stay on treatment. The company raised a $50M Series B led by Oak HC/FT in April 2026.
Dandi Fertility is a New York-based femtech company that makes the physical and emotional grind of IVF a little less lonely. Its patent-pending IVF Care Kit - a heating pad, cooling pad, shot targets, a hands-free supply belt and a massage ball - is paired with a virtual care platform staffed by registered fertility nurses licensed across all 50 states. Founded in 2021 by fertility nurse Leyla Bilali and CEO Jake Kent, Dandi sells directly to patients and to fertility clinics, and its Care Kit was named one of TIME's 200 Best Inventions of 2024.
Daymark Health is a Philadelphia-based, tech-enabled cancer care company that delivers in-home and virtual supportive care to patients during the long stretches between oncology appointments. Working alongside patients' existing oncologists and partnering with health plans under value-based arrangements, Daymark combines a multidisciplinary care team - nurse practitioners, nurses, licensed clinical social workers, and health navigators - with a technology platform to provide 24/7 support, symptom and side-effect management, mental health care, care navigation, and help with practical barriers like transportation and finances.
Medisafe is a digital health company that turns the everyday struggle of taking pills on time into a behavior-driven engagement platform. Born from a near-fatal insulin overdose in the founders' own family, it began as a free virtual pillbox app and grew into an enterprise platform - anchored by Medisafe Maestro and its Just-in-Time Interventions (JITI) engine - that pharmaceutical companies use to keep patients on therapy. With more than 13 million users worldwide and 4+ billion doses tracked, Medisafe sits at the intersection of consumer mobile health and the multibillion-dollar problem of medication non-adherence.
Mike Fitzgibbons is the CEO and Founder of Claritas Rx, a South San Francisco-based healthtech company that uses AI and real-world patient-level data to help biopharmaceutical companies track, understand, and support patients across the specialty drug treatment journey. Founded in 2011, Claritas Rx serves 20+ rare and specialty therapeutic areas and has appeared on Inc.'s 2025 list of America's Fastest-Growing Private Companies. Before founding Claritas Rx, Fitzgibbons spent seven years at Morgan Stanley as an equity research analyst covering pharma services and drug distribution, then joined Genentech where he worked on pricing strategy and led the Avastin marketing team - experiences that directly shaped his conviction that patient-level data, not aggregated reports, is what biopharma companies actually need.